Public consultation: WHO Guidance on reportable changes to PQ-ed and EUL-ed IVDs

Public consultation: WHO Guidance on reportable changes to PQ-ed and EUL-ed IVDs

WHO is seeking for public comments on a new proposed version of the Guidance on reportable changes to IVDs. Manufacturers and other interested stakeholders are invited to share comments on the proposed draft guidance by 15 November 2024. The updated procedure for assessment of changes to IVDs will be implemented as of Q1 2024.

For Public Consultation: New proposed version of the Guidance on reportable changes to IVDs | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)


Emeka Chukwurah

Regulatory Affairs Specialist | Biomedical Scientist | Ensure Compliance with Applicable Regulations for Timely Approval, Commercialization And access to In Vitro Diagnostics Medical Devices in resource limited areas.

4 个月

Irena Prat please do you mean the new guidance document will be implemented in Q1 2025.

回复
Charles Chiku

Technical Officer at World Health Organization

4 个月

An essential resource for ensuring that prequalified IVDs continue to meet safety, quality, and performance standards after changes are implemented. This guidance helps manufacturers understand post-prequalification requirements, facilitating compliance and enhancing the quality of submissions.

回复
Nagaraj Vayyavuru

Business Development I Regulatory operations I eCTD Submissions-RIMS-IDMP-CTIS

4 个月

That's great seeing you are working while you are in India attending ICDRA...

要查看或添加评论,请登录

Irena Prat的更多文章

社区洞察

其他会员也浏览了